STARVIA GLOBAL Offers Cultivated Calculus Bovis Sourcing with Buyer-Selected Independent Laboratory Testing

FOR IMMEDIATE RELEASE

STARVIA GLOBAL Offers Cultivated Calculus Bovis Sourcing with Buyer-Selected Independent Laboratory Testing

Making what is precious less dependent on chance.

STARVIA GLOBAL, a B2B enterprise focused on alternative and cultivated traditional medicine ingredients, today announced the availability of cultivated (in-vitro) Calculus Bovis for qualified buyers and commercial purchasers. This cultivated product provides a traceable, ethical alternative to natural bull gallstone sourcing.

STARVIA GLOBAL clearly identifies this product as IN-VITRO CULTIVATED Calculus Bovis, not a natural product. The cultivated Calculus Bovis is sourced from sampled product report #20260304, dated March 4, 2026, with the following analytical profile: bilirubin at 32.40%, conjugated bile acids at 7.04%, free bile acids at 4.37%, and moisture at 3.50%, with free bilirubin at 0.08%. These four primary values meet the matching 2025 Chinese Pharmacopoeia numeric specification thresholds for natural Calculus Bovis; however, this does NOT establish identical clinical efficacy or regulatory interchangeability between the cultivated and natural products.

STARVIA GLOBAL welcomes purchaser-selected independent reputable laboratory retesting to verify product composition. The company can make the full product report available privately upon request and direct inquiry. Competitive quotations are designed to be below natural bull gallstone sourcing cost, with actual pricing available on direct inquiry.

This press release contains no medical claims. STARVIA GLOBAL is a B2B supply enterprise, not a pharmaceutical manufacturer or healthcare provider.

Product Information:
Product Page: https://starvia-global.arcanegleam512.chatgpt.site/#bovis-focus
Business WhatsApp: https://wa.me/85270102675

Contact:
STARVIA GLOBAL
Email: 506045799@qq.com

###